Why is Flex stock surging today?

Flex (FLEX) stock rose 8.6% pre-market after Q2 2027 earnings beat estimates, with EPS at $1.18 vs. $1.06 and revenue at $8.5B vs. $8.17B. Management raised FY2027 guidance, and BofA reiterated a Buy rating. The stock had previously fallen below its 52-week high of $166.86.

Original reporting
Published Oct 28, 2026, 12:07 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 12:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$FLEX
Bullish
high confidence
Mentioned
$FLEX
Relevance
9/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$FLEXBullishHigh
01

Why it matters

The combination of an earnings beat across key metrics and a raised full-year guidance midpoint is the direct catalyst for the pre-open surge, suggesting a near-term repricing of growth and profitability expectations.

02

Market read

Traders can reassess positioning immediately based on the fresh EPS/revenue beats and the explicit FY2027 guidance midpoint increases.

03

What to watch

The article does not discuss cash flow quality, backlog, or segment-level drivers; those details could determine whether the guidance raise is durable or merely a one-quarter improvement.

Relevance 9/10Novelty 9/10Timing: pre-open today after fiscal Q2 2027 results and same-session guidance raise

Background

Flex had been in a multi-week selloff and was trading well below its 52-week high before the fiscal Q2 2027 results.

Company-level read

Ticker impact

$FLEXBullishHigh confidence
Context

Flex reported fiscal Q2 2027 results with record adjusted EPS of $1.18, revenue $8.5B, and raised full-year FY2027 guidance, driving an 8.6% pre-open surge.

Expected impact

Likely upward pressure as traders price in the raised FY2027 revenue and adjusted EPS midpoints and unwind the prior selloff.

Evidence & confidence

The article cites specific beat metrics and explicit guidance midpoint increases, and ties the move to the pre-open reaction, indicating a direct catalyst for repricing.

Market effects

If sustained, the margin expansion and guidance raise can support sentiment for global manufacturing and supply-chain services peers, though the article is single-name focused.

Limited spillover expected given the neutral-to-modestly-positive US index backdrop described.

Global supply-chain services demand expectations may get a modest read-through, but the article provides no cross-region policy or macro shock.

Counterpoint

The stock’s rebound may be partly mean-reversion after a multi-week selloff; traders could fade the move if the raised guidance is not enough to offset longer-term valuation concerns.

Key entities

  • FLEX

    Global manufacturing and supply chain solutions company reporting fiscal Q2 2027 results and raising FY2027 guidance.

  • BofA Securities

    Reiterated a Buy rating while trimming its price target, framing the selloff as overdone.

Related articles

$FLEXMed

Why is Flex stock climbing today?

Flex Ltd. shares rose 0.8% in pre-market trading after its subsidiary, Axiom, secured a $4.565B credit agreement with Citibank, seen as a step toward Axiom's separation. The deal includes revolving and term loans, with proceeds funding a dividend to Flex. Raymond James reiterated its Outperform rating and $150 price target for Flex. The gains occurred amid recovering U.S. equity futures.

$FLEXMed

Flex stock gains as Axiom subsidiary secures $4.6B credit

Flex Ltd (FLEX) shares rose 2.8% premarket after its subsidiary Axiom secured $4.565B in credit facilities, including a $1.265B revolving credit line and $3.3B in term loans. The funds are pending Axiom's separation from Flex and will support a dividend to Flex for debt prepayment. The loans have floating interest rates and require Axiom to maintain specific leverage and interest coverage ratios.

$FLEXMed

India says Xiaomi, Flextronics hid royalty deals in tariff fight

India accuses Xiaomi and Flex of hiding royalty deals in a tax dispute. The government claims Xiaomi's India unit failed to fully disclose royalty agreements, potentially costing it over $150 million. The case is seen as a test for India's stance on contract manufacturing. Both Xiaomi and Flex have challenged the tax tribunal's rulings, but the government seeks to dismiss these challenges.

$FLEXHigh

KeyBanc cuts Flex stock price target on valuation update

KeyBanc reduced its price target for Flex Ltd. (FLEX) to $128 from $180, citing valuation updates and peer multiple compression. The stock is down 53% from its 52-week high. Flex reported stronger-than-expected Q2 earnings and raised its full-year outlook, leading BofA Securities to raise its target to $162. The company's revenue guidance was increased by $950 million, partly due to recent acquisitions.

$FLEXMedAI 8/10

Flex Outlines FY29 Targets and Axiom’s Growth Plans at Innovation Day

Flex Ltd. outlined FY29 targets and growth plans for Axiom, its planned spin-off. Flex aims for 35-40% revenue from high-value markets, 7%+ adjusted operating margin, and double-digit adjusted EPS growth. Axiom targets $37B+ revenue by 2030, high-teens EBITDA margin, and 90%+ free cash flow conversion. The spin-off is expected in Q1 2027, subject to approvals.